MICHAEL W ROGERS Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MICHAEL W ROGERS.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MICHAEL W ROGERS. MICHAEL W ROGERS is Executive Vice President in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Chief Financial Officer in ACORDA THERAPEUTICS INC ($ACOR) and in EyePoint Pharmaceuticals, Inc. ($EYPT) and Director in pSivida Corp. ($PSDV) and Chief Financial Officer in Aerpio Pharmaceuticals, Inc. ($ZETAII) and Director in Aravive, Inc. ($ARAV) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).

Latest Insider Trading Transactions of MICHAEL W ROGERS

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ACOR, ARPO, AKBA, ARAV, IDEV, EYPT, KERX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 17 2020	ARAV	Aravive, Inc.	ROGERS MICHAEL W	Director	Option Exercise	A	5.99	14,987	89,772	14,987
Sep 17 2020	ARAV	Aravive, Inc.	ROGERS MICHAEL W	Director	Option Exercise	A	5.99	15,024	89,994	15,024
Jun 09 2020	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W		Option Exercise	A	11.96	20,100	240,396	20,100
Jun 09 2020	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W		Grant	A	0.00	13,700	0	38,629	24.9 K to 38.6 K (+54.96 %)
Jun 27 2019	EYPT	EyePoint Pharmaceu ...	ROGERS MICHAEL W		Option Exercise	A	2.65	40,000	106,000	40,000
Jun 24 2019	EYPT	EyePoint Pharmaceu ...	ROGERS MICHAEL W		Option Exercise	M	0.00	6,667	0	0
Jun 24 2019	EYPT	EyePoint Pharmaceu ...	ROGERS MICHAEL W		Buy	M	0.00	6,667	0	119,167	112.5 K to 119.2 K (+5.93 %)
Jun 10 2019	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W		Option Exercise	A	4.23	20,100	85,023	20,100
Jun 10 2019	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W		Grant	A	0.00	13,700	0	24,929	11.2 K to 24.9 K (+122.01 %)
Feb 20 2019	ARPO	Aerpio Pharmaceuti ...	ROGERS MICHAEL W	Chief Financial Off ...	Option Exercise	A	3.27	215,328	704,123	215,328
Feb 20 2019	ARPO	Aerpio Pharmaceuti ...	ROGERS MICHAEL W	Chief Financial Off ...	Option Exercise	A	3.27	215,328	704,123	215,328
Dec 13 2018	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W	Director	Option Exercise	A	8.94	25,000	223,500	25,000
Dec 13 2018	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W	Director	Option Exercise	A	10.05	11,229	112,851	11,229
Dec 13 2018	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W	Director	Option Exercise	A	17.53	11,229	196,844	11,229
Dec 13 2018	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W	Director	Option Exercise	A	15.26	11,229	171,355	11,229
Dec 13 2018	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W	Director	Option Exercise	A	12.48	18,716	233,576	18,716
Dec 13 2018	AKBA	Akebia Therapeutic ...	ROGERS MICHAEL W	Director	Grant	A	0.00	11,229	0	11,229	0 to 11.2 K
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Option Exercise	D	0.00	140,000	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Sell	D	0.00	30,000	0	0	30 K to 0 (-100.00 %)
Nov 16 2018	EYPT	EyePoint Pharmaceu ...	ROGERS MICHAEL W	Director	Option Exercise	M	1.13	100,000	113,000	0
Nov 16 2018	EYPT	EyePoint Pharmaceu ...	ROGERS MICHAEL W	Director	Buy	M	1.13	100,000	113,000	112,500	12.5 K to 112.5 K (+800.00 %)
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Option Exercise	A	3.76	30,000	112,800	30,000
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Grant	A	0.00	10,000	0	30,000	20 K to 30 K (+50.00 %)
Jun 29 2018	PSDV	EyePoint Pharmaceu ...	ROGERS MICHAEL W	Director	Option Exercise	M	0.00	12,500	0	0
Jun 29 2018	PSDV	EyePoint Pharmaceu ...	ROGERS MICHAEL W	Director	Buy	M	0.00	12,500	0	12,500	0 to 12.5 K
Jun 26 2018	PSDV	EyePoint Pharmaceu ...	ROGERS MICHAEL W	Director	Option Exercise	A	0.00	6,667	0	6,667
Jun 26 2018	PSDV	EyePoint Pharmaceu ...	ROGERS MICHAEL W	Director	Option Exercise	A	1.95	26,667	52,001	26,667
Apr 25 2018	ARPO	Aerpio Pharmaceuti ...	ROGERS MICHAEL W	Chief Financial Off ...	Option Exercise	A	3.59	144,000	516,960	144,000
Dec 19 2017	PSDV	pSivida Corp.	ROGERS MICHAEL W	Director	Option Exercise	A	0.00	12,500	0	12,500
Dec 19 2017	PSDV	pSivida Corp.	ROGERS MICHAEL W	Director	Option Exercise	A	1.77	20,000	35,400	20,000
Dec 18 2017	ZETAII	Aerpio Pharmaceuti ...	ROGERS MICHAEL W	Chief Financial Off ...	Option Exercise	A	5.50	293,006	1,611,533	0
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Option Exercise	A	6.56	30,000	196,800	30,000
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Grant	A	0.00	10,000	0	20,000	10 K to 20 K (+100.00 %)
Dec 14 2016	PSDV	pSivida Corp.	ROGERS MICHAEL W	Director	Option Exercise	A	3.49	20,000	69,800	20,000
May 27 2016	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Option Exercise	A	5.71	30,000	171,300	30,000
May 27 2016	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Grant	A	0.00	10,000	0	10,000	0 to 10 K
May 13 2016	ACOR	ACORDA THERAPEUTIC ...	ROGERS MICHAEL W	Chief Financial Off ...	Option Exercise	A	26.40	20,000	528,000	20,000
Mar 04 2016	ACOR	ACORDA THERAPEUTIC ...	ROGERS MICHAEL W	Chief Financial Off ...	Option Exercise	A	35.53	26,796	952,062	26,796
Dec 04 2015	PSDV	pSivida Corp.	ROGERS MICHAEL W	Director	Option Exercise	A	4.09	20,000	81,800	20,000
Dec 03 2015	ACOR	ACORDA THERAPEUTIC ...	ROGERS MICHAEL W	Chief Financial Off ...	Sell	S	38.06	964	36,689	40,713	41.7 K to 40.7 K (-2.31 %)
Oct 09 2015	ACOR	ACORDA THERAPEUTIC ...	ROGERS MICHAEL W	Chief Financial Off ...	Sell	S	30.45	4,433	134,963	41,677	46.1 K to 41.7 K (-9.61 %)
Oct 09 2015	ACOR	ACORDA THERAPEUTIC ...	ROGERS MICHAEL W	Chief Financial Off ...	Sell	S	29.52	1,267	37,396	46,110	47.4 K to 46.1 K (-2.67 %)
Mar 06 2015	ACOR	ACORDA THERAPEUTIC ...	ROGERS MICHAEL W	Chief Financial Off ...	Option Exercise	A	35.74	33,278	1,189,356	33,278
Mar 06 2015	ACOR	ACORDA THERAPEUTIC ...	ROGERS MICHAEL W	Chief Financial Off ...	Grant	A	0.00	5,872	0	47,377	41.5 K to 47.4 K (+14.15 %)
Mar 11 2005	IDEV	Endo Pharmaceutica ...	ROGERS MICHAEL W	Executive Vice Pres ...	Option Exercise	A	3.70	25,000	92,500	25,000
Mar 12 2004	IDEV	Endo Pharmaceutica ...	ROGERS MICHAEL W	Executive Vice Pres ...	Option Exercise	A	5.92	60,000	355,200	60,000

Page: 1